4.3 Article

Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β2 subunit of GABAA receptors

Roland Baur et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Article Pharmacology & Pharmacy

The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABAA receptors

R. Baur et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Article Multidisciplinary Sciences

The major central endocannabinoid directly acts at GABAA receptors

Erwin Sigel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Clinical Neurology

Discovery of Antiepileptic drugs

Misty Smith et al.

NEUROTHERAPEUTICS (2007)

Review Clinical Neurology

Clobazam

Yu-tze Ng et al.

NEUROTHERAPEUTICS (2007)